ATE538203T1 - Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna - Google Patents

Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna

Info

Publication number
ATE538203T1
ATE538203T1 AT05766205T AT05766205T ATE538203T1 AT E538203 T1 ATE538203 T1 AT E538203T1 AT 05766205 T AT05766205 T AT 05766205T AT 05766205 T AT05766205 T AT 05766205T AT E538203 T1 ATE538203 T1 AT E538203T1
Authority
AT
Austria
Prior art keywords
pladienolide
dna
biosynthesis
dna coding
polypeptide involved
Prior art date
Application number
AT05766205T
Other languages
English (en)
Inventor
Kazuhiro Machida
Akira Arisawa
Susumu Takeda
Masashi Yoshida
Toshio Tsuchida
Original Assignee
Eisai R&D Man Co Ltd
Mercian Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd, Mercian Corp filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE538203T1 publication Critical patent/ATE538203T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/08Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT05766205T 2004-07-20 2005-07-19 Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna ATE538203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004211279 2004-07-20
PCT/JP2005/013541 WO2006009276A1 (ja) 2004-07-20 2005-07-19 プラジエノライドの生合成に関与するポリペプチドをコードするdna

Publications (1)

Publication Number Publication Date
ATE538203T1 true ATE538203T1 (de) 2012-01-15

Family

ID=35785378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05766205T ATE538203T1 (de) 2004-07-20 2005-07-19 Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna

Country Status (10)

Country Link
US (1) US8008049B2 (de)
EP (1) EP1770165B1 (de)
JP (1) JP4599357B2 (de)
KR (1) KR100834488B1 (de)
CN (1) CN1977046A (de)
AT (1) ATE538203T1 (de)
AU (1) AU2005265443B2 (de)
CA (1) CA2574092C (de)
IL (1) IL180167A0 (de)
WO (1) WO2006009276A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2546614A1 (en) 2003-11-27 2005-06-09 Mercian Corporation Dna participating in hydroxylation of macrolide compound
EP1770165B1 (de) 2004-07-20 2011-12-21 Eisai R&D Management Co., Ltd. Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna
TW200716744A (en) * 2005-05-26 2007-05-01 Eisai R&D Man Co Ltd Genetically modified microorganism and process for production of macrolide compound using the microorganism
WO2007043621A1 (ja) 2005-10-13 2007-04-19 Eisai R & D Management Co., Ltd. プラジエノライド b及びプラジエノライド dの全合成方法
WO2009147984A1 (ja) 2008-06-04 2009-12-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハーボキシジエンの生合成に関与するポリペプチドをコードするdna
US8865761B1 (en) 2012-08-07 2014-10-21 The University Of Notre Dame Du Lac Regulation of cholesterol homeostasis
KR102146726B1 (ko) 2014-05-15 2020-08-21 에자이 알앤드디 매니지먼트 가부시키가이샤 플라디에놀리드 피리딘 화합물 및 사용 방법
ES2887201T3 (es) 2015-09-01 2021-12-22 Eisai R&D Man Co Ltd Variantes de empalme asociadas con mutantes neomórficos de SF3B1
WO2017087667A1 (en) 2015-11-18 2017-05-26 Eisai R&D Management Co., Ltd. A solid state form of pladienolide pyridine compounds and methods of use
AU2018235940A1 (en) 2017-03-15 2019-10-17 Eisai R&D Management Co., Ltd. Spliceosome mutations and uses thereof
US11524009B2 (en) 2017-10-31 2022-12-13 Eisai R&D Management Co., Ltd. Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use
MX2020010606A (es) 2018-04-09 2021-01-15 Eisai R&D Man Co Ltd Compuestos de pladienolida y su uso.
AU2019252432B2 (en) 2018-04-12 2023-04-13 Eisai R&D Management Co., Ltd. Pladienolide derivatives as spliceosome targeting agents for treating cancer
AU2019279012A1 (en) 2018-06-01 2020-12-24 Eisai R&D Management Co., Ltd. Methods of using splicing modulators
JP2023553588A (ja) 2020-11-04 2023-12-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 骨髄異形成症候群(mds)のバイオマーカー及びその使用方法
WO2023131866A1 (en) 2022-01-05 2023-07-13 Eisai R&D Management Co., Ltd. Biomarkers for myelodysplastic syndrome (mds) and methods of using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
JPH07502650A (ja) 1991-12-16 1995-03-23 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー ストレプトミセスにおけるP450soyおよびフェレドキシン−soyの構成性発現、および組み換え体生物による化学物質の生物変換
ATE346938T1 (de) 1998-10-02 2006-12-15 Kosan Biosciences Inc Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
TWI312681B (en) 2001-02-01 2009-08-01 Novel physiologically active substance
US20030068788A1 (en) 2001-05-16 2003-04-10 Buckel Thomas Gunther Methods and compositions for making emamectin
ITMI20010402U1 (it) 2001-07-18 2003-01-18 Valerio Leccacorvi Rivestimento per le superfici di una piscina
RU2532104C2 (ru) 2001-10-19 2014-10-27 Сумитомо Кемикал Компани, Лимитед Метаболизирующий гербицид белок, его ген и их применение
US6884608B2 (en) 2001-12-26 2005-04-26 Bristol-Myers Squibb Company Compositions and methods for hydroxylating epothilones
AU2003236095A1 (en) 2002-04-12 2003-10-27 Mercian Corporation Expression system of actinomycete-origin cytochrome p-450 in escherichia coli
TWI334866B (en) 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
EP1541570A4 (de) 2002-07-31 2008-05-21 Mercian Corp Neue physiologisch wirksame substanz
CA2494536C (en) 2002-07-31 2011-10-04 Mercian Corporation A 12-membered ring macrolide active substance
NZ540103A (en) 2002-11-29 2007-05-31 Mercian Corp Process for producing macrolide compound
US7416868B2 (en) 2003-01-21 2008-08-26 Thallion Pharmaceuticals, Inc. Polyene polyketides, processes for their production and their use as a pharmaceutical
JP2006528664A (ja) 2003-05-13 2006-12-21 エコピア バイオサイエンシーズ インク ポリエンポリケチド、その調製方法及び医薬品としてのその使用
CA2546614A1 (en) 2003-11-27 2005-06-09 Mercian Corporation Dna participating in hydroxylation of macrolide compound
EP1770165B1 (de) 2004-07-20 2011-12-21 Eisai R&D Management Co., Ltd. Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna
TW200716744A (en) 2005-05-26 2007-05-01 Eisai R&D Man Co Ltd Genetically modified microorganism and process for production of macrolide compound using the microorganism

Also Published As

Publication number Publication date
CA2574092C (en) 2011-08-23
JPWO2006009276A1 (ja) 2008-05-01
KR100834488B1 (ko) 2008-06-09
AU2005265443A1 (en) 2006-01-26
IL180167A0 (en) 2007-06-03
EP1770165A4 (de) 2008-11-12
US20090269820A1 (en) 2009-10-29
EP1770165B1 (de) 2011-12-21
JP4599357B2 (ja) 2010-12-15
CA2574092A1 (en) 2006-01-26
US8008049B2 (en) 2011-08-30
AU2005265443B2 (en) 2008-09-04
KR20070033979A (ko) 2007-03-27
EP1770165A1 (de) 2007-04-04
WO2006009276A1 (ja) 2006-01-26
CN1977046A (zh) 2007-06-06

Similar Documents

Publication Publication Date Title
ATE538203T1 (de) Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna
WO2005001050A3 (en) Transcription factors
MX2009007001A (es) Aminoacidos y polipeptidos fenazina y quinoxalina sustituidos.
DE60142508D1 (de) Menschliche aminoacyl-trna synthetase polypeptide zur regulation der angiogenese
DE602005027093D1 (de) Polypeptide mit lipase-aktivität und diese kodierende polynukleotide
MX2011011215A (es) Polipeptido que degrada carbohidratos y usos del mismo.
DK1369486T3 (da) Plasmid-shuttlevektor mellem Escherichia coli og Brevibacillus
ATE420653T1 (de) Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese
EP1649006A4 (de) Exo-spezifische amylase-polypeptide, diese polypeptide codierende nukleinsäuren und verwendungen davon
DE60335794D1 (de) Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden
MX2021014057A (es) Polipéptidos de sintasas de cannabinoides optimizados.
DE602005020972D1 (en) Rhamnosepromotor-expressionssystem
WO2006042719A3 (de) Polypeptid mit phytaseaktivität und dieses codierende nucleotidsequenz
DE69913285D1 (de) DsbA/DsbB/DsbC/DsbD Expressionsplasmid
DK1756273T3 (da) Signalpeptid til frembringelse af et polypeptid
MX2008002115A (es) Componentes de transporte de nitrato.
DE60043470D1 (de) Pflanzliche Defensine
EP1870454A4 (de) Verfahren zur dipeptidherstellung
EP1642971A4 (de) Fucosetransporter
EP1634954A4 (de) Protease, für die protease codierende dna und verfahren zur herstellung der protease
HUP0500349A2 (hu) Eljárás polipeptidek előállítására
ATE350477T1 (de) Für phosphoglucomutasen aus glycine max plastiden kodierende nukleinsäuren
MX2012001109A (es) Sistema mejorado de expresion de pentraxina 3 larga humana y usos del mismo.
EP1384776A4 (de) An der zytokininsynthese beteiligte proteine codierende gene
DE602005018326D1 (de) Für orotat-transporter codierende markergene